Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David R Nelson, MD
University of Florida
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University
Palo Alto, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Medstar Health Research Institute
Washington D.C., District of Columbia, United States
- Uf Hepatology Research at Ctrb
Gainesville, Florida, United States
- Uf Health Jacksonville-Gastroenterology Emerson
Jacksonville, Florida, United States
- Schiff Center for Liver Diseases/university of Miami
Miami, Florida, United States
- Orlando Immunology Center
Orlando, Florida, United States
- Atlanta Gastro Associates
Atlanta, Georgia, United States
- Atlanta Medical Center
Atlanta, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- the Johns Hopkins Hospital/john G. Bartlett Specialty Practice
Baltimore, Maryland, United States
- Digestive Disease Associates, Pa
Catonsville, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Univ. of Minnesota Health Clinics and Surgery Center, Inc.
Minneapolis, Minnesota, United States
- Southern Therapy and Advanced Research
Jackson, Mississippi, United States
- Northwell Health - Sandra Atlaas Bass Center for Liver Diseases
Manhasset, New York, United States
- Columbia University Medical Center
New York, New York, United States
- Nyu Langone Medical Center
New York, New York, United States
- Weill Cornell Medicine, Hepatology
New York, New York, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- the Ohio State University
Columbus, Ohio, United States
- Integris Baptist Medical Center
Oklahoma City, Oklahoma, United States
- University of Pennsylvania-Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Bon Secours Liver Institute of Virginia
Richmond, Virginia, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
- University of Washington
Seattle, Washington, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Apr 2017
- Primary completion
- 28 Dec 2018
- Completion
- 6 Feb 2020
- Last update posted
- 26 Feb 2020
- Registered enrollment
- 177
- Registry id
- NCT03092375
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.